Utama › Glomerulosklerosis Segmental Fokal › Minnesota
Kajian klinikal Glomerulosklerosis Segmental Fokal di Minnesota
5 kajian untuk Glomerulosklerosis Segmental Fokal sedang mencari peserta di lokasi di Minnesota.
Bandar di Minnesota
Teks kajian rasmi (Bahasa Inggeris)
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- InterMed Consultants - Edina Clinic- Site Number : 8400019, Edina
Mengambil pesertaFasa 2
Umur 16 hingga 75 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06500702Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- University of Minnesota, Minneapolis
Mengambil peserta
Sehingga umur 21 · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT02235857Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- University of Minnesota, Masonic Children's Hospital, Minneapolis
Mengambil pesertaFasa 2
Umur 1 hingga 17 · Semua jantina · Dikemas kini 12 Mei 2026 · NCT05003986SLIT ABS: Study on Patients With Autoimmune Podocytopathy
- Mayo Clinic, Rochester
Mengambil peserta
Umur 0 hingga 99 · Semua jantina · Dikemas kini 8 Apr 2026 · NCT07516964A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- University of Minnesota, Minneapolis
Mengambil pesertaFasa 3
Umur 12 hingga 80 · Semua jantina · Dikemas kini 3 Feb 2026 · NCT05183646Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.